laboratori corp america hold lh nyse qqq
though labcorp first-quart result solid full
forc yet emerg
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research apr
estim apr
price data apr
rate updat apr
currenc amount express
methodolog valu compani
look rel healthi though clearli
caus dramat turn last half march weve
increment lower fair valu estim roughli
per share incorpor estim
declin diagnost revenu temper covanc
growth expect full year new project
similar revis assumpt quest diagnost
contract research organ howev
expect labcorp fare margin better quest due
higher proport esoter test hurt
less sever routin test take good sign
covanc didnt see unusu cancel activ
first quarter fulli expect biopharmaceut
client delay trial activ weigh near-
manag indic crisi lower
first-quart revenu growth roughli basi point
far beyond rel paltri
impact pama reimburs cut quest
declin came last two week
march diagnost volum declin
normal level increas capac
diagnost test wasnt nearli enough off-set
loss test exampl labcorp typic
handl approxim half million test per day
current capac diagnost
test daili basi moreov manag indic
recent diagnost test level fallen
short capac labcorp quest aim increas
capac even
remain concern even two largest
independ lab increas capac diagnost test
exist lab infrastructur still wont enough
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
laboratori corpor america one nation two largest
independ clinic laboratori roughli independ lab
offer broad rang clinic lab test rang routin blood
urin screen complex oncolog genom test
addit covanc labcorp also sizabl footprint global
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
laboratori corp america hold lh nyse qqq
safe gradual allow peopl resum normal
econom activ rel limit capac
entir lab network handl molecular diagnost
test leav us precari posit
actual identifi interven see second wave
hot spot develop later year
hand labcorp quest anticip theyll
abl ramp blood-bas antibodi test
patient would provid us rear-view
mirror look wide spread howev
antibodi test help identifi patient
activ infect may shed viru
also unansw question much
immun gener long would last protect
recov reinfect
expect eas use sizabl capac run
antibodi test mean adopt ramp next
coupl quarter recogn util limit
final think situat underscor
appeal coupl labcorp diagnost expertis
covanc drug develop busi
begun creat patient databas
tend reli patient self-identifi contrast
labcorp patient databas contain
confirm infect particularli use
biopharma compani may look activ
infect patient particip trial determin
clinic valu variou treatment
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
laboratori corp america hold lh nyse qqq
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
laboratori corp america hold lh nyse qqq
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
